HYPD
HYPD
NASDAQ · Pharmaceuticals

Hyperion Defi Inc

$2.49
-0.07 (-2.73%)
As of Nov 7, 2:41 AM ET ·
Day Range $2.36 — $2.67
52W Range $2.34 — $6.48
Open$2.60
Previous Close$2.56
Day High$2.67
Day Low$2.36
52W High$6.48
52W Low$2.34
Volume—
Avg Volume229.4K
Market Cap39.47M
P/E Ratio5.93
EPS$-2.10
SectorPharmaceuticals

Analyst Ratings

Strong Buy
8 analysts
7 Buy 1 Hold 0 Sell
Price Target +548.2% upside
Current
$2.49
Target
$16.14
$9.68 $16.14 avg $20.98

Key Financials

FY 2026 FY 2025 FY 2024
Revenue 2.58M 4.90M 5.01M
Net Income -143,650,775 -3,832,248,999 1.46M
Profit Margin -5,570.6% -82,538.4% 29.2%
EBITDA -140,667,528 -3,873,168,857 1.99M
Free Cash Flow — — 1.60M
Rev Growth — -84.0% +22.0%
Debt/Equity 0.19 1.59 0.45

Pharmaceuticals Peers

Symbol Name Price Change P/E Mkt Cap
LLY Eli Lilly and Co. $1,354.00 -0.79% 46.6 1.28T
JNJ Johnson & Johnson $276.22 +1.43% 40.8 656.45B
MRK Merck & Co. Inc. $146.73 -0.14% 147.8 362.53B
PFE Pfizer Inc. $29.39 -1.64% 41.4 167.12B
BMY Bristol-Myers Squibb Co $62.14 -1.57% 13.8 127.96B
ZTS Zoetis Inc $79.40 -3.30% 12.8 33.59B

Next Earnings

Nov 12, 2026
Before Market Open
4 days away
EPS Est: $1.85

Quick Stats

Market Cap39.47M
P/E Ratio5.93
EPS$-2.10
Volume—
SectorPharmaceuticals